These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39146895)

  • 1. Implication of Apolipoprotein E gene variants in pediatric-onset multiple sclerosis: Possible association with disease susceptibility and its clinical characteristics, in a Hellenic cohort.
    Skarlis C; Markoglou N; Artemiadis A; Gontika M; Koutsis G; Chrousos G; Anagnostouli M
    Mult Scler Relat Disord; 2024 Oct; 90():105797. PubMed ID: 39146895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of HLA-DRB1 alleles in a Hellenic, Pediatric-Onset Multiple Sclerosis cohort: Implications on clinical and neuroimaging profile.
    Skarlis C; Markoglou N; Gontika M; Artemiadis A; Pons MR; Stefanis L; Dalakas M; Chrousos G; Anagnostouli M
    Neurol Sci; 2024 May; ():. PubMed ID: 38819529
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Gontika M; Skarlis C; Artemiadis A; Pons R; Mastroyianni S; Vartzelis G; Theodorou V; Kilindireas K; Stefanis L; Dalakas M; Chrousos G; Anagnostouli M
    Mult Scler J Exp Transl Clin; 2020; 6(1):2055217320908046. PubMed ID: 32133149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis.
    McKay KA; Manouchehrinia A; Berrigan L; Fisk JD; Olsson T; Hillert J
    JAMA Neurol; 2019 Sep; 76(9):1028-1034. PubMed ID: 31206130
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Anagnostouli M; Artemiadis A; Gontika M; Skarlis C; Markoglou N; Katsavos S; Kilindireas K; Doxiadis I; Stefanis L
    Brain Sci; 2020 Jun; 10(6):. PubMed ID: 32560041
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous Mass Spectrometry-Based Apolipoprotein Profiling and Apolipoprotein E Phenotyping in Patients with ASCVD and Mild Cognitive Impairment.
    Begcevic Brkovic I; Zöhrer B; Scholz M; Reinicke M; Dittrich J; Kamalsada S; Baber R; Beutner F; Teren A; Engel C; Wirkner K; Thiele H; Löffler M; Riedel-Heller SG; Ceglarek U
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of apolipoprotein E (ApoE) polymorphisms with risk of primary hyperuricemia in Uygur men, Xinjiang, China.
    Sun YP; Zhang B; Miao L; Wang XM; Yu JH; Luo L; Ying L; Xin G; Haliakpaer G; Xia H; Yao H
    Lipids Health Dis; 2015 Apr; 14():25. PubMed ID: 25890021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What an adult multiple sclerosis registry can tell us about pediatric onset multiple sclerosis?
    Alkolfat F; Said S; Mekky J; Eldeeb H
    Mult Scler Relat Disord; 2023 Nov; 79():104962. PubMed ID: 37714097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data.
    Gontika M; Skarlis C; Markoglou N; Evangelopoulos ME; Velonakis G; Chrousos GP; Dalakas M; Stefanis L; Anagnostouli M
    Neurol Sci; 2022 Apr; 43(4):2641-2649. PubMed ID: 34596776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Sclerosis Progression and Relapse Activity in Children.
    Iaffaldano P; Portaccio E; Lucisano G; Simone M; Manni A; Guerra T; Paolicelli D; Betti M; De Meo E; Pastò L; Razzolini L; Rocca MA; Ferrè L; Brescia Morra V; Patti F; Zaffaroni M; Gasperini C; De Luca G; Ferraro D; Granella F; Pozzilli C; Romano S; Gallo P; Bergamaschi R; Coniglio MG; Lus G; Vianello M; Banfi P; Lugaresi A; Totaro R; Spitaleri D; Cocco E; Di Palma F; Maimone D; Valentino P; Torri Clerici V; Protti A; Maniscalco GT; Salemi G; Pesci I; Aguglia U; Lepore V; Filippi M; Trojano M; Amato MP;
    JAMA Neurol; 2024 Jan; 81(1):50-58. PubMed ID: 38010712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis.
    Baruch NF; O'Donnell EH; Glanz BI; Benedict RH; Musallam AJ; Healy BC; Rintell D; Chitnis T
    Mult Scler; 2016 Mar; 22(3):354-61. PubMed ID: 26041802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
    Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
    J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes on Social and Classic Cognition in adults with Pediatric-onset Multiple Sclerosis.
    Massano C; Lima M; Monteiro I; Machado R; Correia I; Nunes CC; Macário C; Sousa L; Santana I; Batista S
    Mult Scler Relat Disord; 2021 Aug; 53():103071. PubMed ID: 34161899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis.
    E P; M S; E P; A B; L P; M N; L R; R F; L T; M F; A G; L P; Mg M; E C; G F; F P; C C; M F; L M; E M; Rg V; L M; B G; Mp A
    Mult Scler Relat Disord; 2020 Jul; 42():102145. PubMed ID: 32408152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis.
    Horton MK; Shim JE; Wallace A; Graves JS; Aaen G; Greenberg B; Mar S; Wheeler Y; Weinstock-Guttman B; Waldman A; Schreiner T; Rodriguez M; Tillema JM; Chitnis T; Krupp L; Casper TC; Rensel M; Hart J; Quach HL; Quach DL; Schaefer C; Waubant E; Barcellos LF
    Mult Scler; 2023 Apr; 29(4-5):505-511. PubMed ID: 36755464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of quality of life in pediatric- and adult-onset multiple sclerosis.
    McKay KA; Ernstsson O; Manouchehrinia A; Olsson T; Hillert J
    Neurology; 2020 Mar; 94(9):e932-e941. PubMed ID: 31732567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution.
    Ziaei A; Lavery AM; Shao XM; Adams C; Casper TC; Rose J; Candee M; Weinstock-Guttman B; Aaen G; Harris Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Hart J; Waldman AT; Barcellos LF; Waubant E
    Mult Scler; 2022 Aug; 28(9):1330-1339. PubMed ID: 35000467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients.
    Menascu S; Khavkin Y; Zilkha-Falb R; Dolev M; Magalashvili D; Achiron A; Gurevich M
    Ann Clin Transl Neurol; 2021 Jan; 8(1):81-94. PubMed ID: 33197148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.
    Ziaei A; Solomon O; Casper TC; Waltz M; Weinstock-Guttman B; Aaen G; Wheeler Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Waldman AT; Krupp L; James JA; Hart J; Barcellos LF; Waubant E
    Mult Scler; 2024 Mar; 30(3):308-315. PubMed ID: 38332747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.